NCT00508963No Longer Available不适用
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Biopsy proven new world cutaneous or mucocutaneous leishmania
排除标准
- •Prolonged QT
- •Liver disease
- •Pancreatitis
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Sodium Stibogluconate Treatment of LeishmaniasisLeishmaniasisNCT00662012U.S. Army Medical Research and Development Command414
终止
2 期
Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396Cutaneous LeishmaniasisNCT00657917U.S. Army Medical Research and Development Command1
招募中
1 期
Subcutaneous Semaglutide in Systemic SclerodermaScleroderma, SystemicFibrosisSemaglutideNCT06149260Second Xiangya Hospital of Central South University10
已完成
2 期
Miltefosine to Treat Cutaneous Leishmaniasis in BoliviaCutaneous LeishmaniasisNCT00233545AB Foundation80
招募中
不适用
eech treatment of Leishmaniasis lesioIRCT20211211053349N3Kerman University of Medical Sciences2